We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+32.42%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$703M
AUM Growth
+$202M
Cap. Flow
+$117M
Cap. Flow %
16.67%
Top 10 Hldgs %
43.13%
Holding
134
New
60
Increased
28
Reduced
13
Closed
31

Top Buys

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$12.9M
2
XRAY icon
Dentsply Sirona
XRAY
+$9.25M
3
BSX icon
Boston Scientific
BSX
+$7.14M
4
VRAY
ViewRay, Inc.
VRAY
+$7.09M
5
GILD icon
Gilead Sciences
GILD
+$6.65M

Top Sells

Rank Stock Value
1
SIBN icon
SI-BONE Inc
SIBN
+$4.49M
2
AMGN icon
Amgen
AMGN
+$3.89M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$3.33M
4
TNDM icon
Tandem Diabetes Care
TNDM
+$2.99M
5
AMRN
Amarin Corp
AMRN
+$2.78M

Sector Composition

Rank Sector Weight
1 Healthcare 36.29%
2 Industrials 0.63%
3 Financials 0.27%
4 Technology 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MGNX icon
101
CALL
MacroGenics
MGNX
$249M
$243K 0.03%
+13,500
New +$233K
GRCE
102
Grace Therapeutics
GRCE
$44.6M
$212K 0.03%
4,335
+413
+11% +$20.4K
AGRX
103
DELISTED
Agile Therapeutics
AGRX
$112K 0.02%
+37
New +$78.4K
ABT icon
104
CALL
Abbott
ABT
$190B
– –
-200,000
Closed -$14.5M
ADMA icon
105
ADMA Biologics
ADMA
$2.22B
– –
-37,170
Closed -$131K
AMGN icon
106
Amgen
AMGN
$224B
– –
-20,000
Closed -$3.89M
AMGN icon
107
PUT
Amgen
AMGN
$224B
– –
-33,200
Closed -$6.46M
ATRC icon
108
AtriCure
ATRC
$2.18B
– –
-90,030
Closed -$2.75M
CARM
109
DELISTED
Carisma Therapeutics
CARM
– –
-10,000
Closed -$284K
DGX icon
110
PUT
Quest Diagnostics
DGX
$26.2B
– –
-50,000
Closed -$4.16M
EXEL icon
111
CALL
Exelixis
EXEL
$12.7B
– –
-110,700
Closed -$2.18M
EXEL icon
112
Exelixis
EXEL
$12.7B
– –
-86,055
Closed -$1.69M
INCY icon
113
CALL
Incyte
INCY
$24.5B
– –
-210,000
Closed -$13.4M
INGN icon
114
CALL
Inogen
INGN
$157M
– –
-40,000
Closed -$4.97M
INGN icon
115
Inogen
INGN
$157M
– –
-4,669
Closed -$580K
INSP icon
116
CALL
Inspire Medical Systems
INSP
$1.71B
– –
-75,000
Closed -$3.17M
KOD icon
117
Kodiak Sciences
KOD
$2.64B
– –
-24,319
Closed -$173K
MDT icon
118
CALL
Medtronic
MDT
$116B
– –
-400,000
Closed -$36.4M
OFIX icon
119
CALL
Orthofix Medical
OFIX
$420M
– –
-50,000
Closed -$2.63M
PRQR icon
120
ProQR Therapeutics
PRQR
$271M
– –
-76,827
Closed -$1.21M
RIGL icon
121
Rigel Pharmaceuticals
RIGL
$785M
– –
-33,206
Closed -$764K
SIBN icon
122
SI-BONE Inc
SIBN
$843M
– –
-214,684
Closed -$4.49M
SNDX icon
123
CALL
Syndax Pharmaceuticals
SNDX
$1.81B
– –
-110,700
Closed -$493K
VNDA icon
124
PUT
Vanda Pharmaceuticals
VNDA
$298M
– –
-34,400
Closed -$899K
VRCA icon
125
Verrica Pharmaceuticals
VRCA
$89.7M
– –
-6,392
Closed -$521K
2 3 4
5
6

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q1 2019 Portfolio in Review

As of Q1 2019, Pura Vida Investments held 134 positions worth $703M, up 40% from $501M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Pura Vida Investments deployed $117M of net new capital in Q1 2019, opening 60 new positions and adding to 28 existing holdings. Its largest new stake was Zimmer Biomet: 113,300 shares worth $14M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 28% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Tandem Diabetes Care, an estimated $2.99M trimmed.

  • Pura Vida Investments's largest Q1 2019 buy was Zimmer Biomet: 113,300 shares worth $14M.
  • Pura Vida Investments added most to Boston Scientific in Q1 2019, an estimated $7.14M increase.
  • Pura Vida Investments's biggest Q1 2019 reduction was Tandem Diabetes Care, cutting an estimated $2.99M.
  • Pura Vida Investments fully exited SI-BONE Inc in Q1 2019, selling an estimated $4.49M.
  • Pura Vida Investments's ten largest holdings make up 43% of its $703M portfolio in Q1 2019.
  • Pura Vida Investments opened 60 new positions and closed 31 in Q1 2019.
  • Pura Vida Investments's portfolio value rose 40% quarter-over-quarter to $703M.

Based on Pura Vida Investments's 13F filing for Q1 2019, filed 14 May 2019.